生物技术公司Kallyope获1.12亿美元C轮融资，推进其项目组合-动脉橙

生物技术公司Kallyope获1.12亿美元C轮融资，推进其项目组合

2020-03-25 biospace 等6家媒体报道投融资





3月25日，生物技术公司Kallyope宣布获得1.12亿美元C轮融资，投资方包括现有的投资者Column Group、Lux Capital、Polaris Partners和Bill Gates，以及新投资者Casdin Capital，Greenspring Associates和两名未具名的领先机构投资者参与。融资资金将用来推进其计划组合和首次临床试验。

关联公司

 Kallyope

关联机构

 The Column GroupLux CapitalPolaris PartnersEuclidean CapitalTwo Sigma VenturesIllumina VenturesAlexandria Venture InvestmentsCasdin CapitalGreenspring Associates

2020-03-25 Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis

biospace
2020-03-25 Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis

vcaonline
2020-03-25 Kallyope Announces $112M Series C Round

vcnewsdaily
2020-03-25 Kallyope Raises $112M in Series C Financing

FinSMEs
2020-03-25 Kallyope Gains $112M to Move “Gut-Brain Axis” Programs to the Clinic

Xconomy
2020-03-25 Kallyope Prepares to Enter the Clinic Following $112 Million Financing Round

biospace